■ Jornal da USP – HIV/AIDS

https://jornal.usp.br/tag/hivaids/

 

■ Who wants to switch? Gauging patient interest in novel antiretroviral therapies

Caroline B Derrick, Jan Ostermann, Sharon B Weissman et al

Open Forum Infect Dis. 2018 Oct; 5(10): ofy247

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197380/

 

■ Immediate start of antiretroviral, why not?.

Matsuda, Elaine Monteiro et AL

Braz J Infect Dis, June 2018, vol.22, no.3, p.250-251

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000300250&lng=pt&nrm=iso

 

■ Is visceral leishmaniasis the same in HIV-coinfected adults?

Henn, Guilherme Alves de Lima et al.

Braz J Infect Dis, Mar 2018, vol.22, no.2, p.92-98

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000200092&lng=en&nrm=iso

 

■ Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?

Maciel, Ethel L. et al.

Braz J Infect Dis, Jan 2018, vol.22, no.1, p.74-75

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000100074&lng=en&nrm=iso

 

■ Are traditional body fat equations and anthropometry valid to estimate body fat in children and adolescents living with HIV?

Lima, Luiz Rodrigo Augustemak de et al.

Braz J Infect Dis, Aug 2017, vol.21, no.4, p.448-456

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000400448&lng=en&nrm=iso

 

■ HIV testing after a first positive rapid diagnostic test: a role for nucleid acid testing

Anne M Neilan, Jennifer E Cohn, Jean-Francois Lemaire et al

Open Forum Infect Dis. 2018 Aug; 5(8): ofy170

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114195/

 

■ Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: Is urine lipoarabinomannan testing the answer?

Natasha F. Sabur, Aliasgar Esmail, Mantaj S. Brar, Keertan Dheda

BMC Infect Dis. 2017; 17: 803

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745979/

 

■ A systematic review of adherence to oral pre-exposure prophylaxis for HIV – How can we improve uptake and adherence?

David Sidebottom, Anna Mia Ekström, Susanne Strömdahl

BMC Infect Dis. 2018; 18: 581

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240194/

 

■ Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Antonio Di Biagio, Marta Ameri, Davide Sirello et AL

BMC Infect Dis. 2017; 17: 127.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294769/

 

■ Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – Which method to choose for the diagnosis?

Ana Rita Coelho, Flávia Andreia Moreira, Ana Cristina Santos et al

BMC Infect Dis. 2018; 18: 309

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035413/

 

■ Cardiac steatosis in HIV- A marker or mediator of disease?

Morgan Jacob, Cameron J. Holloway

Front Endocrinol (Lausanne) 2018; 9: 529

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193415/

 

■ Are women living with HIV prone to osteoporosis in postmenopause? A systematic review.

Cezarino, Pérsio Yvon Adri et al.

Rev. Assoc. Med. Bras., May 2018, vol.64, no.5, p.469-473

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000500469&lng=pt&nrm=iso

 

■ Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?

Ramos, Grazielle Viana et al.

Clinics, 2018, vol.73

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000100205&lng=en&nrm=iso

 

■ How should HIV resources be allocated? Lessons learnt from applying optima HIV in 23 countries

Robyn M Stuart, Laura Grobicki, Hassan Haghparast‐Bidgoli, et al

J Int AIDS Soc. 2018 Apr; 21(4): e25097

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898225/

 

■ How common and frequent is hererosexual anal intercourse among South Africans? A systematic review and meta-analysis

Branwen N. Owen, Jocelyn Elmes, Romain Silhol et al

J Int AIDS Soc. 2017; 20(1): 21162

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461120/

 

■ Pregnant adolescents living with HIV: What we know, what we need to know, where we need to go

Tegan Callahan, Surbhi Modi, Jennifer Swanson, Bernadette Ng’eno, Laura N. Broyles

J Int AIDS Soc. 2017; 20(1): 21858

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577684/

 

■ Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: systematic review and meta-analysis

Jessica de Mattos Costa, Thiago Silva Torres, Lara Esteves Coelho, Paula Mendes Luz

J Int AIDS Soc. 2018 Jan; 21(1): e25066

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810329/

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com